These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 24462945)

  • 1. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
    Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
    Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
    Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
    Ariaans G; Jalving M; Vries EG; Jong S
    BMC Cancer; 2017 Mar; 17(1):232. PubMed ID: 28356082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
    PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.
    Marinello PC; da Silva TN; Panis C; Neves AF; Machado KL; Borges FH; Guarnier FA; Bernardes SS; de-Freitas-Junior JC; Morgado-Díaz JA; Luiz RC; Cecchini R; Cecchini AL
    Tumour Biol; 2016 Apr; 37(4):5337-46. PubMed ID: 26561471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
    Dowling RJ; Zakikhani M; Fantus IG; Pollak M; Sonenberg N
    Cancer Res; 2007 Nov; 67(22):10804-12. PubMed ID: 18006825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of metformin on MDA-MB-231 breast cancer cells in a monolayer culture and in tumor spheroids as a function of nutrient concentrations.
    Bizjak M; Malavašič P; Pirkmajer S; Pavlin M
    Biochem Biophys Res Commun; 2019 Jul; 515(2):296-302. PubMed ID: 31146913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
    Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
    J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
    Liu B; Fan Z; Edgerton SM; Deng XS; Alimova IN; Lind SE; Thor AD
    Cell Cycle; 2009 Jul; 8(13):2031-40. PubMed ID: 19440038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
    Gao Z; Shi M; Wang Y; Chen J; Ou Y
    Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.